Trump Administration Axes Moderna’s Bird Flu Vaccine Contract

Thursday, May 29, 2025, 11:21 am

The Trump administration abruptly canceled a $766 million Moderna contract aimed at developing a pandemic flu vaccine. Critics bemoan the decision as a prime example of erratic policy pivots, leaving both industry insiders and public health experts scratching their heads over the sudden switch in strategy.

Bluesky: @patriotprogressive.bsky.social, @tigerpournelle.bsky.social

theepochtimes.com / Health Department Cancels More Than $700 Million in Funding for Moderna’s Bird Flu Vaccine

Keeping the money in place 'was not scientifically or ethically justifiable,' a spokesperson for the department said.

cnbc.com / Trump administration cancels $766 million Moderna contract to fight pandemic flu

The Trump administration canceled $766 million awarded to Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including bird flu.

cbsnews.com / Why is Trump's administration cutting bird flu vaccine funding?

The Health and Human Services Department has canceled millions of dollars in funding for the drugmaker Moderna to develop a bird flu vaccine. CBS News health reporter Alex Tin has the details.

cbsnews.com / Trump administration pulls bird flu, other vaccine funding awarded to Moderna

The Department of Health and Human Services withdrew $766 million awarded to Moderna to develop a vaccine against potential pandemic flu viruses like the bird flu. Infectious disease physician Dr. Peter Chin-Hong joins CBS News to discuss.

alternet.org / 'Absolutely terrified': Trump HHS slammed for axing human bird flu vaccine contract

The Trump administration Department of Health and Human Services has canceled a $766 million contract with Moderna to complete the development of a vaccine to protect humans against potential pandemic flu viruses, including bird flu. Outbreaks in animals have hit all 50 U.S. states and the disease…


permalink / 5 stories from sources in 2 days ago #trump #healthcare #politics #moderna




More Top Stories...


Rapid Growth in Iran’s Near Weapons-Grade Uranium Stockpile

Independent assessments show that Iran has significantly hiked its stockpile of uranium enriched near weapons grade. UN watchdog reports and other sources underscore mounting concerns about Iran’s nuclear ambitions and the potential military applications of this dangerous buildup. More...


Gaza Ceasefire Talks: Hamas Demands and Israeli Warnings

Hamas officials have vehemently rejected a US-backed ceasefire proposal, demanding additional guarantees before halting hostilities in Gaza. In a parallel development, an Israeli defense official warned that failure to comply with the ceasefire terms could trigger severe consequences, underscoring the fragile progress amid intensifying tensions. More...


Gaza Aid Trucks Ransacked Amid Crisis

In a troubling display of desperation, nearly 80 UN and WFP aid trucks loaded with food were reportedly ransacked by hungry Palestinians in Gaza. The incidents, a stark reminder of the dire humanitarian crisis gripping the region, have ignited fresh concerns over the plight of civilians amid ongoing instability. More...


German Leader to Meet Trump at White House In-Person Summit

Germany’s newly appointed chancellor is set to meet President Trump in Washington this week for his first in-person encounter at the White House. The meeting comes amid shifting transatlantic relations and diplomatic recalibrations, offering insight into the evolving U.S.-German policy dynamic. More...


DOE cancels $3.7B in Biden-era green energy awards

In a move that hardly inspires a standing ovation from the climate crowd, the administration canceled $3.7 billion in Biden-era green energy awards. Critics bemoan the sidelining of carbon-capture and renewable projects, questioning whether bureaucratic enthusiasm outweighed genuine environmental commitment. More...



Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.